We recognise the great work our member ACCHOs do in hepatitis B and C prevention by promoting vaccination, harm minimisation strategies, and reducing stigma and discrimination.
Aboriginal people are a priority population in the NSW Health Hepatitis B and Hepatitis C Strategies, with our ACCHOS playing a vital role in offering testing and treatment options with linkage to specialist care to reduce the impact of viral hepatitis.
To support the important work of our members, AH&MRC is committed to ongoing awareness-raising efforts in the prevention and management of Viral Hepatitis.
Some fast facts from Hepatitis Australia:
- In Australia, nearly 1000 people die every year due to Hepatitis B and Hepatitis C.
- Hepatitis B can be successfully avoided through vaccination. People living with hepatitis B can be managed with available treatments.
- Hepatitis C can be effectively treated with Direct-Acting Antivirals (DAA) in 8-12 weeks.
Upcoming event:
The International Network on Health and Hepatitis in Substance Users (INHSU) symposium is open to all healthcare providers that are interested in using evidence-based interventions to develop or upscale the implementation of Hepatitis C models of care in their service.
Date: Thursday 4th September
Time: 9.30am-3pm
Location: International Towers, 100 Barangaroo Avenue, Sydney
Cost: FREE to attend but registration is essential
Register here
